GPT and metabolic dysfunction-associated steatotic liver disease: Chachay and his colleagues [25] found an increment in AST and ALT after supplementing NAFLD patients with 3000 mg of resveratrol, while supplementing 600 mg and 150 mg of resveratrol for 12 weeks did not induce changes in AST, ALT, and GGT levels [26,28].